 LA JOLLA, Calif., April 19, 2021 GLOBE NEWSWIRE -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market NASDAQ:MNOV and the JASDAQ Market of the Tokyo Stock Exchange Code Number: 4875, today announced that Yuichi Iwaki, MD, PhD, President and Chief Executive Officer, and Geoffrey OBrien, JDMBA, Vice President and Executive Officer, will participate in a fireside chat, hosted by B. Riley Analyst Mayank Mamtani, regarding MediciNovas development of MN-166 ibudilast for neurological conditions at the virtual B. Riley Neuroscience Conference on Thursday, April 29, 2021 at 1:30 p.m. ET. MediciNova will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through B. Riley. 